Colibri Heart Valve, LLC Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System  
1/29/2013 9:33:59 AM

BROOMFIELD, CO, Jan. 29, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. More particularly, today the U.S. Patent & Trademark Office granted Colibri U.S. Patent No. 8,361,144 entitled, "Percutaneously Deliverable Heart Valve Device And Methods Associated Therewith." The patent is directed to a method of making a pre-packaged, sterilized, dry heart valve pre-mounted on a delivery system. The patent provides Colibri with intellectual property rights extending into 2031 for the significant medical device market concerning prosthetic heart valves. Colibri is also seeking patent rights in a number of foreign countries.